The Role of Tau in Alzheimer's Disease and Related Disorders

被引:208
|
作者
Medeiros, Rodrigo
Baglietto-Vargas, David
LaFerla, Frank M. [1 ]
机构
[1] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA
关键词
Alzheimer's disease; ss-Amyloid; Hyperphosphorylation; Kinase; Neurofibrillary tangles; Neuron; Phosphatase; Tau protein; Tauopathies; PAIRED HELICAL FILAMENTS; MICROTUBULE-ASSOCIATED PROTEINS; GLYCOGEN-SYNTHASE KINASE-3; BRAIN GLUCOSE-METABOLISM; TRIPLE-TRANSGENIC MODEL; DEGENERATION IN-VIVO; MOUSE MODEL; NEUROFIBRILLARY DEGENERATION; A-BETA; HYPERPHOSPHORYLATED-TAU;
D O I
10.1111/j.1755-5949.2010.00177.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tau, the microtubule-associated protein, forms insoluble filaments that accumulate as neurofibrillary tangles in Alzheimer's disease (AD) and related tauopathies. Under physiological conditions, tau regulates the assembly and maintenance of the structural stability of microtubules. In the diseased brain, however, tau becomes abnormally hyperphosphorylated, which ultimately causes the microtubules to disassemble, and the free tau molecules aggregate into paired helical filaments. A large body of evidence suggests that tau hyperphosphorylation results from perturbation of cellular signaling, mainly through imbalance in the activities of different protein kinases and phosphatases. In AD, it appears that ss-amyloid peptide (Ass) plays a pivotal role in triggering this imbalance. In this review, we summarize our current understanding of the role of tau in AD and other tauopathies, and highlight key issues that need to be addressed to improve the success of developing novel therapies.
引用
收藏
页码:514 / 524
页数:11
相关论文
共 50 条
  • [41] Alzheimer's disease and related disorders annual 2001
    Burke, WJ
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (09): : 1610 - 1611
  • [42] Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
    Nicholas J. Ashton
    Mark Ide
    Henrik Zetterberg
    Kaj Blennow
    [J]. Neurology and Therapy, 2019, 8 : 83 - 94
  • [43] Blood Tests for Alzheimer's Disease and Related Disorders
    Reiman, E. M.
    [J]. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2019, 6 (03): : 155 - 156
  • [44] Progression of Atrophy in Alzheimer’s Disease and Related Disorders
    Jennifer L. Whitwell
    [J]. Neurotoxicity Research, 2010, 18 : 339 - 346
  • [45] Translational proteomics in Alzheimer's disease and related disorders
    Ghidoni, Roberta
    Paterlini, Anna
    Benussi, Luisa
    [J]. CLINICAL BIOCHEMISTRY, 2013, 46 (06) : 480 - 486
  • [46] Blood Tests for Alzheimer’s Disease and Related Disorders
    Eric M. Reiman
    [J]. The Journal of Prevention of Alzheimer's Disease, 2019, 6 : 155 - 156
  • [47] Effects of Hypertension on Alzheimer's Disease and Related Disorders
    Malone, Joseph E.
    Elkasaby, Mohamed, I
    Lerner, Alan J.
    [J]. CURRENT HYPERTENSION REPORTS, 2022, 24 (12) : 615 - 625
  • [48] Alzheimer's disease and related disorders annual 2005
    Engedal, Knut
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2006, 18 (04) : 760 - 761
  • [49] Neurochemical biomarkers in Alzheimer's disease and related disorders
    Bibl, Mirko
    Esselmann, Hermann
    Wiltfang, Jens
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2012, 5 (06) : 335 - 348
  • [50] Alzheimer's disease and related disorders Annual 2002
    Ganguli, M
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2004, 16 (02) : 239 - 242